Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan
· Delayed Price · Currency is TWD 20.00
-0.05 (-0.25%)
Mar 10, 2026, 1:41 PM CST
Anxo Pharmaceutical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 314.32 | 358.92 | 295.43 | 241.32 | 214.18 | 207.76 | Upgrade
|
| Short-Term Investments | - | 2.23 | 89.75 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 314.32 | 361.14 | 385.18 | 241.32 | 214.18 | 207.76 | Upgrade
|
| Cash Growth | -10.14% | -6.24% | 59.61% | 12.67% | 3.09% | 16.96% | Upgrade
|
| Accounts Receivable | 197.98 | 210.5 | 249.71 | 240.86 | 208.64 | 191.06 | Upgrade
|
| Other Receivables | 6.97 | 4.67 | 11.36 | 10.63 | 10.42 | 10.26 | Upgrade
|
| Receivables | 204.95 | 215.17 | 261.07 | 251.49 | 219.07 | 201.32 | Upgrade
|
| Inventory | 263.94 | 262.42 | 283.86 | 243.1 | 238.88 | 267.03 | Upgrade
|
| Prepaid Expenses | 14.71 | 18.15 | 22.19 | 14.88 | 17.11 | 10.96 | Upgrade
|
| Other Current Assets | 25.98 | 21.69 | 25.99 | 20.7 | 15.54 | 17.61 | Upgrade
|
| Total Current Assets | 823.89 | 878.56 | 978.29 | 771.5 | 704.78 | 704.69 | Upgrade
|
| Property, Plant & Equipment | 1,039 | 1,038 | 1,079 | 1,110 | 1,140 | 1,152 | Upgrade
|
| Long-Term Investments | 52.56 | 52.56 | 30 | - | - | - | Upgrade
|
| Goodwill | 36.61 | 36.61 | 36.61 | 36.61 | 36.61 | 36.61 | Upgrade
|
| Other Intangible Assets | 8.38 | 9.84 | 3.77 | 4.95 | 4.3 | 5.01 | Upgrade
|
| Long-Term Deferred Tax Assets | 41.71 | 34.38 | 22.03 | 18.75 | 11.77 | 7.45 | Upgrade
|
| Other Long-Term Assets | 49.54 | 57.8 | 68.82 | 32.79 | 21.81 | 7.55 | Upgrade
|
| Total Assets | 2,052 | 2,108 | 2,219 | 1,974 | 1,919 | 1,913 | Upgrade
|
| Accounts Payable | 62.61 | 81.55 | 79.69 | 94.03 | 78.43 | 76.79 | Upgrade
|
| Accrued Expenses | 71.84 | 88.43 | 75.35 | 71.58 | 66.73 | 73.94 | Upgrade
|
| Short-Term Debt | 220 | 205 | 215 | 256.38 | 215 | 199.63 | Upgrade
|
| Current Portion of Long-Term Debt | 61.6 | 63.46 | 58.5 | 57.55 | 64.68 | 56.82 | Upgrade
|
| Current Portion of Leases | 13.48 | 9.36 | 14.65 | 11.5 | 8.69 | 8.04 | Upgrade
|
| Current Income Taxes Payable | - | - | 6.68 | 6.76 | 4.33 | 2.09 | Upgrade
|
| Current Unearned Revenue | 22.04 | 20.07 | 5.43 | 14.47 | 5.04 | 12.39 | Upgrade
|
| Other Current Liabilities | 39.18 | 34.76 | 31.42 | 42.8 | 29.95 | 36.17 | Upgrade
|
| Total Current Liabilities | 490.75 | 502.61 | 486.72 | 555.07 | 472.84 | 465.87 | Upgrade
|
| Long-Term Debt | 412.78 | 437.61 | 480.7 | 528.08 | 572.61 | 622.25 | Upgrade
|
| Long-Term Leases | 10.97 | 11.2 | 19 | 33.57 | 21.49 | 2.35 | Upgrade
|
| Long-Term Unearned Revenue | 16.11 | 16.21 | 27.73 | 26.49 | 18.09 | 9.94 | Upgrade
|
| Other Long-Term Liabilities | 1.34 | 0.58 | 1.19 | 1.26 | 2.02 | 1.34 | Upgrade
|
| Total Liabilities | 931.96 | 968.21 | 1,015 | 1,144 | 1,087 | 1,102 | Upgrade
|
| Common Stock | 558.71 | 558.14 | 556.64 | 481.64 | 481.64 | 458.7 | Upgrade
|
| Additional Paid-In Capital | 459.03 | 483.68 | 478.85 | 211.08 | 206.62 | 205.91 | Upgrade
|
| Retained Earnings | -20.27 | -25.46 | 54.01 | 32.14 | 44.7 | 48.4 | Upgrade
|
| Comprehensive Income & Other | 6 | 6 | - | - | - | - | Upgrade
|
| Total Common Equity | 1,003 | 1,022 | 1,089 | 724.86 | 732.96 | 713.02 | Upgrade
|
| Minority Interest | 116.27 | 117 | 113.76 | 104.78 | 98.99 | 98.44 | Upgrade
|
| Shareholders' Equity | 1,120 | 1,139 | 1,203 | 829.64 | 831.94 | 811.46 | Upgrade
|
| Total Liabilities & Equity | 2,052 | 2,108 | 2,219 | 1,974 | 1,919 | 1,913 | Upgrade
|
| Total Debt | 718.83 | 726.63 | 787.84 | 887.09 | 882.47 | 889.08 | Upgrade
|
| Net Cash (Debt) | -404.51 | -365.49 | -402.66 | -645.76 | -668.29 | -681.32 | Upgrade
|
| Net Cash Per Share | -7.25 | -6.56 | -7.81 | -13.41 | -13.78 | -14.18 | Upgrade
|
| Filing Date Shares Outstanding | 55.87 | 55.81 | 55.66 | 48.16 | 48.16 | 48.16 | Upgrade
|
| Total Common Shares Outstanding | 55.87 | 55.81 | 55.66 | 48.16 | 48.16 | 48.16 | Upgrade
|
| Working Capital | 333.14 | 375.94 | 491.57 | 216.43 | 231.93 | 238.82 | Upgrade
|
| Book Value Per Share | 17.96 | 18.32 | 19.57 | 15.05 | 15.22 | 14.80 | Upgrade
|
| Tangible Book Value | 958.48 | 975.92 | 1,049 | 683.3 | 692.04 | 671.4 | Upgrade
|
| Tangible Book Value Per Share | 17.16 | 17.49 | 18.85 | 14.19 | 14.37 | 13.94 | Upgrade
|
| Land | 576.53 | 576.53 | 576.53 | 576.53 | 576.53 | 576.53 | Upgrade
|
| Buildings | 418.52 | 417.99 | 417.99 | 416.05 | 417.89 | 416.12 | Upgrade
|
| Machinery | 488.35 | 463.03 | 464.55 | 434.6 | 436.82 | 410.26 | Upgrade
|
| Construction In Progress | 8.51 | 9.88 | - | - | - | - | Upgrade
|
| Leasehold Improvements | 14.93 | 15.9 | 3.99 | 2.02 | 10.09 | 9.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.